Medsmart Wellness Centers, a Subsidiary of Med Holdings Group Inc., Expands Telemedicine and Announces Strategic Partnerships
DENVER, CO AND MIAMI, FL / ACCESSWIRE / September 12, 2024 / Med Holdings Group Inc. (OTC PINK:YUKA), the parent...
Healthcare
Sema Slim: A New Safe and Effective Medical Weight Loss Solution Now Available Online
MIAMI, FL / ACCESSWIRE / September 12, 2024 / Sema Slim™, the premier online destination for effective telehealth services in...
Beacon Oral Specialists Announces Strategic Partnerships With Oral Surgery Partners and Vero Beach Surgical Arts
Newest Agreements Welcome Five Surgeons; Expand Footprint in Southern California, FloridaDALLAS, TX / ACCESSWIRE / September 12, 2024 / Beacon...
HeartSciences Closes Non-Dilutive Financing to Increase its Cash Runaway Ahead of Upcoming FDA Submission
Southlake, TX, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the...
PeopleOne Health and RosenCare Enhance Employee Healthcare with Innovative Model for Orange County Public Schools
Four new health centers to open across Orlando, boosting access to high quality and affordable healthcare in the regionORLANDO, Fla.,...
Johnson & Johnson seeks first EU approval of nipocalimab to treat a broad population of patients living with antibody-positive generalised myasthenia gravis
Marks first EMA submission for nipocalimab, an investigational treatment that binds with high affinity and specificity to block FcRn and...
Noom Introduces Industry-First $149 Compounded GLP-1 with a Taper-Off Guarantee, Offering a Sustainable Approach to Long-Term Weight Loss
Starting price of $149 offers improved accessibility compared to market prices of brand-name medications which can be 8x higher.Noom stands...
Solid Biosciences to Participate at the 2024 Cantor Global Healthcare Conference
CHARLESTOWN, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company” or “Solid”), a life sciences...
Sharps Technology Announces Continued Listing on Nasdaq Pending Results of an Upcoming Special Shareholders’ Meeting
NEW YORK, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc., (NASDAQ: STSS and STSSW) (“Sharps Technology” or the “Company”),...
Newly Published Review Highlights the Pivotal Role of Daxor’s Blood Volume Analysis Technology in Advancing Cardiorenal Syndrome Management
Review Published in the Prestigious Journal Cardiorenal Medicine Oak Ridge, TN, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq:...
Keros Therapeutics Announces Updated Time of Presentation at 2024 Cantor Global Healthcare Conference
LEXINGTON, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical...
Biogen Board Appoints Two New Independent Directors
Dr. Lloyd Minor and Prof Sir Menelas Pangalos bring significant scientific expertise and considerable experience in medicine research and developmentCAMBRIDGE,...
Intellia Therapeutics to Present Data from the Phase 2 Study of NTLA-2002 for the Treatment of Hereditary Angioedema (HAE) at the 2024 ACAAI Annual Scientific Meeting
First presentation of detailed Phase 2 results following previous positive topline announcement that study of NTLA-2002 met primary and all...
Enable Injections Announces Agreement with Sobi® to Develop and Distribute Aspaveli® in Combination with enFuse® in Sobi Territories
CINCINNATI, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Enable Injections, Inc. (“Enable”), a healthcare innovation company developing and manufacturing the enFuse® wearable drug...
VitalCaring’s AI-driven Cognitive Care Pilot Shows Promising Results
National leader in home health and hospice care to extend AI-enabled speech, language, and cognitive therapy initiative across its network...
Oruka Therapeutics Announces $200 Million Private Placement
MENLO PARK, Calif., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (“Oruka” or the “Company”) (Nasdaq: ORKA), a biotechnology...
Invivyd at the Ready for Upcoming Respiratory Virus Season with PEMGARDA™ (pemivibart) to Help Protect Vulnerable Immunocompromised Persons from COVID-19
Centers for Disease Control and Prevention (CDC) reports death rate due to COVID-19 has continued to increase throughout 2024 Immunocompromised...
Seres Therapeutics Reports SER-155 Phase 1b Placebo-Controlled Cohort 2 Study Safety and Clinical Results in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT)
SER-155 administration was associated with a significant reduction in both bacterial bloodstream infections (BSIs) and systemic antibiotic exposure, as well...
F2G Announces $100 Million Financing to Advance Late-Stage Development and Commercialization of Novel Antifungal Drug Candidate Olorofim in the US
Financing is being led by new investor AMR Action Fund with strong participation from new investor ICG Life Sciences and...
Aclarion Provides Corporate Update on Nociscan AI Technology Milestones
Successful milestones achieved and upcoming include peer-reviewed publications, commercial agreements, and payer coverage decisions Progressing with proven path toward standard...